- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 211 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 275 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 224 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 93 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 93 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 377 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 288 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 383 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 582 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 395 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 483 Pages
Global
From €5240EUR$5,850USD£4,467GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more